Filing Analysis

📄 Other SEC Filing Filed Jun 11, 2026
⚪ LOW

Nkarta, Inc. reported the results of its 2026 annual meeting of stockholders held on June 10, 2026. The meeting included the election of Class III directors, ratification of the independent auditor, and advisory votes on executive compensation.

📋 Key Facts

  • Elected Class III directors Ali Behbahani, M.D., M.B.A. and Zachary Scheiner, Ph.D. to serve until the 2029 annual meeting.
  • Ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
  • Approved executive compensation on a non-binding advisory basis (43,493,065 votes For).
  • Determined to hold future advisory votes on executive compensation every year based on stockholder voting results.
📄 Other SEC Filing Filed May 12, 2026
⚪ LOW

Nkarta, Inc. announced its financial results for the first quarter ended March 31, 2026, via a press release. The filing includes corporate highlights and standard financial performance disclosures for the period.

📋 Key Facts

  • The filing was made on May 12, 2026.
  • Financial results pertain to the first quarter ended March 31, 2026.
  • The report was filed under Item 2.02 (Results of Operations and Financial Condition).
  • Exhibit 99.1 contains the full press release titled 'Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights'.
💸 Securities Offering Filed Mar 26, 2026
🟡 MEDIUM

Nkarta, Inc. has entered into a sales agreement with Stifel, Nicolaus & Company to establish an at-the-market (ATM) offering program for up to $100 million of its common stock. This allows the company to sell shares periodically at its discretion to raise capital.

🚩 Red Flags

  • Potential for significant shareholder dilution
  • Need for substantial capital infusion often precedes high cash burn in biotech

📋 Key Facts

  • Entered into a Sales Agreement with Stifel on March 25, 2026
  • Aggregate offering price of up to $100,000,000
  • Sales agent commission is up to 3% of gross proceeds
  • Shares will be sold under a Form S-3 registration statement (File No. 333-294611)
📢 Regulation FD Disclosure Filed Mar 25, 2026
⚪ LOW

Nkarta, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025. The filing serves as a formal disclosure of the company's year-end performance and corporate highlights via a press release.

📋 Key Facts

  • Financial results reported for the period ending December 31, 2025.
  • The report was filed on March 25, 2026.
  • The filing includes Exhibit 99.1, a press release detailing corporate highlights and financial performance.
  • Information provided under Item 2.02 is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for NKTX

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial